The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 6 , Pages 1588-1596 , June 2007

Lipopolysaccharide preconditioning induces robust protection against brain injury resulting from deep hypothermic circulatory arrest

Presented as a poster presentation at the Thirty-second Annual Meeting of the Western Thoracic Surgical Association, Sun Valley, Idaho, June 21-24, 2006.

  • Edward J. Hickey, MRCS

      Affiliations

    • Department of Pediatric Cardiac Surgery, Oregon Health Sciences University, Portland, Ore
    • Corresponding Author InformationAddress for reprints: Edward J. Hickey, MD, CHSS Data Center, Hospital for Sick Children, 555 University Ave, Toronto, Ontario M5G 1X8, Canada.
    • ,
  • Xiaomang You, MD

      Affiliations

    • Department of Pediatric Cardiac Surgery, Oregon Health Sciences University, Portland, Ore
    • ,
  • Vassil Kaimaktchiev, MD

      Affiliations

    • Department of Neuropathology, Oregon Health Sciences University, Portland, Ore
    • ,
  • Mary Stenzel-Poore, PhD

      Affiliations

    • Department of Immunology, Oregon Health Sciences University, Portland, Ore.
    • ,
  • Ross M. Ungerleider, MD

      Affiliations

    • Department of Pediatric Cardiac Surgery, Oregon Health Sciences University, Portland, Ore

Received 27 July 2006 ,Revised 15 November 2006 ,Accepted 18 December 2006.

References 

  1. Hertzog PJ, O’Neill LA, Hamilton JA. The interferon in TLR signaling: more than just antiviral. Trends Immunol. 2003;24:534–539
  2. Hill JK, Gunion-Rinker L, Kulhanek D, Lessov N, Kim CS, Clark WM, et al. Temporal modulation of cytokine expression following focal cerebral ischemia in mice. Brain Res. 1999;820:45–54
  3. Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, et al. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet. 2003;362:1028–1037
  4. Rosenzweig HL, Lessov NS, Henshall DC, Minami M, Simon RP, Stenzel-Poore MP. Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke. 2004;35:2576–2581
  5. Schultz JM, Karamlou T, Swanson J, Shen I, Ungerleider R. Hypothermic low-flow cardiopulmonary bypass impairs pulmonary and right ventricular function more than circulatory arrest. Ann Thorac Surg. 2006;81:474–480
  6. Schmued L, Albertson C, Slikker W. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 1997;751:37–46
  7. Cammermeyer J. The importance of avoiding the “dark” neurons in experimental neuropathology. Acta Neuropathol. 1961;1:245–270
  8. Martin LJ, Sieber FE, Traystman RJ. Apoptosis and necrosis occur in separate neuronal populations in hippocampus and cerebellum after ischemia and are associated with differential alterations in metabotropic glutamate receptor signaling pathways. J Cereb Blood Flow Metab. 2000;20:153–167
  9. Kerendi F, Halkos ME, Kin H, Corvera JS, Brat DJ, Wagner MB, et al. Upregulation of hypoxia inducible factor is associated with attenuation of neuronal injury in neonatal piglets undergoing deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 2005;130:1079
  10. Yeh CH, Wang YC, Wu YC, Lin YM, Lin PJ. Ischemic preconditioning or heat shock pretreatment ameliorates neuronal apoptosis following hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 2004;128:203–210
  11. Tasaki K, Ruetzler CA, Ohtsuki T, Martin D, Nawashiro H, Hallenbeck JM. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 1997;748:267–270
  12. Fernandez ED, Flohe S, Siemers F, Nau M, Ackermann M, Ruwe M, et al. Endotoxin tolerance protects against local hepatic ischemia/reperfusion injury in the rat. J Endotoxin Res. 2000;6:321–328
  13. Dawson DA, Furuya K, Gotoh J, Nakao Y, Hallenbeck JM. Cerebrovascular hemodynamics and ischemic tolerance: lipopolysaccharide-induced resistance to focal cerebral ischemia is not due to changes in severity of the initial ischemic insult, but is associated with preservation of microvascular perfusion. J Cereb Blood Flow Metab. 1999;19:616–623
  14. Shum-Tim D, Nagashima M, Shinoka T, Bucerius J, Nollert G, Lidov HG, et al. Postischemic hyperthermia exacerbates neurologic injury after deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 1998;116:780–792
  15. Ye J, Yang L, Del Bigio MR, Filgueiras CL, Ede M, Summers R, et al. Neuronal damage after hypothermic circulatory arrest and retrograde cerebral perfusion in the pig. Ann Thorac Surg. 1996;61:1316–1322
  16. Klaus S, Heringlake M, Block K, Nolde J, Staubach K, Bahlmann L. Metabolic changes detected by microdialysis during endotoxin shock and after endotoxin preconditioning. Intensive Care Med. 2003;29:634–641
  17. Tuor UI, Del Bigio MR, Chumas PD. Brain damage due to cerebral hypoxia/ischemia in the neonate: pathology and pharmacological modification. Cerebrovasc Brain Metab Rev. 1996;8:159–193
  18. Zhao P, Zuo Z. Prenatal hypoxia-induced adaption and neuroprotection that is inducible nitric oxide–synthase dependent. Neurobiol Dis. 2005;20:871–880
  19. Eklind S, Mallard C, Arvidsson P, Hagberg H. Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr Res. 2005;58:112–116
  20. Gidday JM, Shah AR, Maceren RG, Wang Q, Pelligrino DA, Holtzman DM, et al. Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning. J Cereb Blood Flow Metab. 1999;19:331–340
  21. Heurteaux C, Lauritzen I, Widmann C, Lazdunski M. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc Natl Acad Sci U S A. 1995;92:4666–4670
  22. Nandagopal K, Dawson TM, Dawson VL. Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. J Pharmacol Exp Ther. 2001;297:474–478
  23. Chen J, Graham SH, Zhu RL, Simon RP. Stress proteins and tolerance to focal cerebral ischemia. J Cereb Blood Flow Metab. 1996;16:566–577
  24. Bordet R, Deplanque D, Maboudou P, Puisieux F, Pu Q, Robin E, et al. Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance. J Cereb Blood Flow Metab. 2000;20:1190–1196
  25. Wietek C, Miggin SM, Jefferies CA, O’Neill LA. Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kappa. J Biol Chem. 2003;278:50923–50931
  26. Kariko K, Weissman D, Welsh FA. Inhibition of toll-like receptor and cytokine signaling—a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab. 2004;24:1288–1304
  27. Nawashiro H, Martin D, Hallenbeck JM. Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res. 1997;778:265–271
  28. Furuya K, Ginis I, Takeda H, Chen Y, Hallenbeck JM. Cell permeable exogenous ceramide reduces infarct size in spontaneously hypertensive rats supporting in vitro studies that have implicated ceramide in induction of tolerance to ischemia. J Cereb Blood Flow Metab. 2001;21:226–232
  29. Liu H, Xin L, Chan BP, Teoh R, Tang BL, Tan YH. Interferon-beta administration confers a beneficial outcome in a rabbit model of thromboembolic cerebral ischemia. Neurosci Lett. 2002;327:146–148
  30. Dalpke AH, Lehner MD, Hartung T, Heeg K. Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance. Immunology. 2005;116:203–212

 Supported by generous grants from the Medical Research Foundation of Oregon and the Children’s Heart Foundation, which have funded both this study and the considerable preliminary work necessary.

PII: S0022-5223(07)00243-7

doi: 10.1016/j.jtcvs.2006.12.056

The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 6 , Pages 1588-1596 , June 2007

Article Tools

* Image Usage & Resolution